Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5067256012 | Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5067257015 | Etofylline 84.7 mg/mL and theophylline anhydrous 25.3 mg/mL solution for injection | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has manufactured dose form | Solution for injection | true | Inferred relationship | Some | ||
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has precise active ingredient | Etofylline | true | Inferred relationship | Some | 2 | |
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | Etofylline | true | Inferred relationship | Some | 2 | |
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | Product containing only etofylline and theophylline in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has precise active ingredient | Theophylline anhydrous | true | Inferred relationship | Some | 1 | |
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) | Has basis of strength substance (attribute) | Theophylline anhydrous | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets